Covestor’s ImmunityBio IBRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$10K Sell
1,074
-59
-5% -$472 0.01% 1457
2026
Q2
$10K Buy
1,133
+1,073
+1,788% +$8.12K 0.01% 1589
2026
Q1
$0 Buy
60
+1
+2% +$7 ﹤0.01% 2498
2025
Q4
$0 Sell
59
-1
-2% -$2 ﹤0.01% 2473
2025
Q3
$0 Hold
60
– – ﹤0.01% 2494
2025
Q2
$0 Sell
60
-4
-6% -$11 ﹤0.01% 2446
2025
Q1
$0 Buy
64
+29
+83% +$88 ﹤0.01% 2450
2024
Q4
$0 Buy
35
+2
+6% +$8 ﹤0.01% 2461
2024
Q3
$0 Sell
33
-2
-6% -$9 ﹤0.01% 2442
2024
Q2
$0 Hold
35
– – ﹤0.01% 2460
2024
Q1
$0 Sell
35
-43
-55% -$195 ﹤0.01% 2457
2023
Q4
$0 Buy
78
+41
+111% +$129 ﹤0.01% 2378
2023
Q3
$0 Sell
37
-5
-12% -$10 ﹤0.01% 2363
2023
Q2
$0 Sell
42
-1
-2% -$3 ﹤0.01% 2358
2023
Q1
$0 Hold
43
– – ﹤0.01% 2273
2022
Q4
$0 Sell
43
-2
-4% -$11 ﹤0.01% 2292
2022
Q3
$0 Sell
45
-9
-17% -$41 ﹤0.01% 2259
2022
Q2
$0 Sell
54
-15
-22% -$60 ﹤0.01% 2116
2022
Q1
$0 Sell
69
-15
-18% -$92 ﹤0.01% 2256
2021
Q4
$1K Buy
+84
New +$631 ﹤0.01% 1784

Other funds holding IBRX

Covestor's IBRX Position: Q3 2026 in Review

Covestor reduced its ImmunityBio (IBRX) stake by 5.2% in Q3 2026, selling an estimated $472 and leaving 1,074 shares worth $10K. The position accounts for 0.01% of the portfolio, ranked #1457.

Covestor first reported a position in IBRX in Q4 2021 and has held it in 20 quarters since. 123 funds tracked by Wall St. Rank hold IBRX as of Q3 2026.

  • Covestor held 1,074 shares of ImmunityBio worth $10K as of Q3 2026.
  • Covestor sold 59 ImmunityBio shares in Q3 2026, an estimated $472.
  • ImmunityBio made up 0.01% of Covestor's portfolio in Q3 2026, its #1457 holding.
  • Covestor first reported a position in ImmunityBio in Q4 2021 and has held it in 20 quarters since.
  • 123 funds tracked by Wall St. Rank held ImmunityBio as of Q3 2026.

Based on Covestor's 13F filing for Q3 2026, filed 30 Oct 2026.